Back to NewsPublished: 16 Jan 2026Download AppJoin TelegramCipla Stock Drops 4.6% After USFDA Pauses Lanreotide – Investors Should Know#Cipla#USFDA#Pharmaceutical StocksDownload AppJoin CommunityShare Article